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Results:
 
 26 congenital and 114 childhood AVB were included. Symptoms
lead to diagnosis in 15,6% whereas AVB was asymptomatic in 84,4%. 73%
AVB were complete and 26,2% AVB were incomplete at first presentation. 21
of these incomplete blocks (56,7%) progressed to permanent complete AVB.
Narrow QRS complexes were found in 69,2% congenital and 91,2% childhood
AVB. In the 112 (79,4%) implanted children, mean duration between AVB dia-
gnosis and pacemaker implantation was 35 months. Pacemaker primo-implanta-
tion occurred during the first year of life for 18 children and 90 children (63.8%)
were paced before 10 years old. Pacing was required for symptomatic brady-
cardia in 37,5% whereas prophylactic cardiac pacing accounted for 61,6%. The
median follow-up was 96 months (from 6 to 384 months). 85,1% experienced
no complication and neither dilated cardiomyopathy nor death had occurred at
last follow-up. Pacemaker-related complications appeared in 11,6%.
 
Conclusion:
 
 We describe the largest reported experience with isolated and
non immune congenital and childhood AVB. Such a block is a nodal damage
from unknown origin that may postnatally progress in incomplete forms. Out-
come is not influenced by age at diagnosis. Prognosis is very good with no
late-onset dilated cardiomyopathy, a few pacemaker-related complications in
the modern technological era and no death at last follow-up.
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Background:
 
 Pulmonary arterial hypertension (PAH) is a rare but devas-
tating complication of bone marrow transplantation (BMT). It has been
reported after BMT for malignant disease or immune deficiencies.
Methods : Over a period of 10 years, all children with PAH after BMT were
reviewed for underlying disease, pre-BMT conditioning, associated hepatic
veno-occlusive disease, characteristics of PAH, management of PAH and out-
come.
 
Results:
 
 14 patients were diagnosed to have PAH after BMT (mean age 8.5
months, mean age at BMT 5.7 months). The underlying disease was an immune
deficiency in 11 cases and a malignant disease in 3 cases. Eleven patients
received chemoprophylaxis before BMT and conditioning was the same in all
cases. Seven patients had a hepatic veno-occlusive disease before the onset of
PAH. PAH appeared 40 days after BMT (4-96 days). The presenting symptom
was dyspnea in 13 cases and syncope in 1 case. Extensive microbiological inves-
tigations were negative in all patients. PAH was diagnosed on echocardiography
in all cases and confirmed by right heart catheterization in 7 cases. All patients
had normal wedge pressure. Acute vasodilation testing with NO˚ was positive in
4/14. Histology was performed in 1/14 patient and showed arteriolar lesions.
Six/14 patients needed mechanical ventilation, 12/14 received specific therapies
for PAH. Five patients died. PAH resolved in the remaining 9 patients after a
follow-up of 3 months. All the survivors had a favourable haematological issue.
 
Conclusion:
 
 PAH after BMT is a rare complication that occurs mainly in
infants less than 2 years of age. It is inconstantly preceded by hepatic veno-
occlusive disease. Mortality is high but reversibility is constant in survivors
suggesting that an aggressive treatment should be early proposed.
 
296
 
Usefullness of three-dimensional echocardiography for the diagnosis
of bicuspid aortic valve : a pediatric study
 
Pierre-Emmanuel Seguela, Brice Arnaudis, Romain Amadieu, Yves
Dulac, Philippe Acar 
 
Hôpital des Enfants - CHU de Toulouse, Cardiologie Pédiatrique, 
Toulouse, France
 
Background:
 
 The bicuspid aortic valve (BAV) is the most common con-
genital heart defect. Children with BAV are more likely to have valve dys-
function and to require intervention during childhood. According to the
subtype of BAV, the prognosis and the treatment may be different.
 
Objective:
 
 The aim of this study was to assess the accuracy of 3D echocar-
diography (3DE) in order to diagnose BAV and to depict accurately the leaf-
lets morphology.
 
Methods:
 
 40 consecutive children with suspicion of BAV were included in
a prospective monocentric study. 2DE and 3DE views were recorded by the
same investigator. Images were reviewed separately by two confirmed pedi-
atric cardiologists in order to assess BAV. Then, we compared 2DE and 3DE
for the description of the spatial position of cusps and raphes. The association
with aortic aneurysms, aortic valve insufficiency or stenosis and other cardiac
malformation were also reported.
 
Results:
 
 The median age was 4.8 years (± 7.3). For 19 patients (47%), 3DE
allows a better visualization of the leaflets morphology leading to a reclassifica-
tion of the BAV. Raphes are better distinguished by 3D live (sensitivity = 100%
[CI95%, 88-100], specificity = 100% [CI95%, 67-100]) or biplane echocardio-
graphy (sensitivity = 96% [CI95%, 80-99], specificity = 63% [CI95%, 35-85])
than 2DE (sensitivity = 86% [CI95%, 62-96], specificity = 28% [14-50]). Inter-
observer variability is almost null.
 
Conclusion:
 
 3D live and biplane echocardiography is a simple, rapid and
reliable method for the diagnosis and the accurate description of BAV in chil-
dren. This technique may be particularly helpful in order to precise the prog-
nosis or to guide the surgeon. 
 
Keywords:
 
 Bicuspid aortic valve, Three-dimensional echocardiography. 
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Purpose: 
 
Late after total correction, Fallot patients with a long QRS dura-
tion are prone to serious arrhythmias and cardiac death. However, knowledge
about long-term electrocardiographic changes after Fallot repair is limited.
 
Methods: 
 
 Measurements were performed on ECGs recorded preopera-
tively, postoperatively and during annual follow-up of 35 Fallot patients
included in 3 groups: G1 if they received no patch (n=7), G2 if they received
a transannular patch (n=13) and G3 if they received a pulmonary homograft
(n=15).
Bicuspid aortic valve assessed by 3DE
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Results:
 
 The AV conduction time increased over the time in all groups (Z-
score: from 0.9±1.1 to 1.3±0.9 in G1, 0.9±1.2 to 1.7±1.6 in G2 and 0.7±0.7 to
1.4±1.3 in G3). One G2 patient and two G3 patients had increased PQ duration
>200 msec at late follow-up. The QRS duration increased during the follow-
up at a rate of 1.78 msec/year in G1, 2.34 msec/year in G2 despite pulmonary
valve replacement in 10 patients, and 1.81 msec/year in G3 despite conduit
replacement in 9. At the later follow-up, the QRS duration was significantly
increased (Z-score: 4.5±3.6 in G1, 5.7±1.4 in G2 and 4.6±1.9 in G3). One
patient in each group had QRS duration of 170 msec or longer and the one in
G3 had a history of serious ventricular arrhythmia. Three patients had a QTc
duration above 460 msec.
 
Conclusions:
 
 Conduction disorders are noted at late follow-up in Fallot
patients who received transannular patch but also in those who received no
patch or a pulmonary homograft. It suggests that volume overloading related
to the transannular patch but also chronic pressure overloading and myocardial
injury related to surgery also contribute to the development of conduction dis-
orders. We suggest that all Fallot patients should undergo regular ECG follow-
up and that, in those with signs of conduction disorders, further diagnostic pro-
cedures should be considered.
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Introduction:
 
 Percutaneous atrial septal defect (ASD) closure is now a
safe and efficient alternative to surgery in adults. In paediatric population, its
feasibility is still uncertain and limited in young children with large defect.
Our aim was to determine predictive factors of success of percutaneous ASD
closure in this population. 
 
Methods:
 
 All patients less than 12 years-old who underwent an attempt of
a percutaneous ASD closure using Amplatzer septal occluder device were ret-
rospectively reviewed. We analysed by echocardiography ASD diameter,
length of rims surrounding, length of atrial septum, and during catheterization
balloon-stretched diameter. ASD area was calculated and normalized to the
body surface area of patients. The procedure was abandoned when the device
placement failed after three attempts. 
 
Results:
 
 140 patients (age 7.7±2.5 years, weight 25.3±9 kg) were included.
Echocardiographic ASD diameter was 15±4.1 mm, balloon-stretched diameter
19.8±4.7mm, length of atrial septum 34.8±5.9 mm, diameter of implanted
device 18.6±4.3 mm. All rims surrounded ASD measuring at least 3 mm. Per-
cutaneous closure was successfully performed in 131 patients and failed in
8 patients. One device embolization into right atria occurred without any com-
plication leads to surgery. Predictive factors of success included smaller ASD
echocardiographic and balloon-stretched diameters (14.6±3.8 vs 19.9±4.4 mm,
p<0.001 and 19.0±0.6 vs 25.6±6.3 mm, p<0.001), smaller ratio ASD area/
body surface area (338±139 vs 569±210, p<0.05), smaller device size
(18.3±3.9 vs 22.4±5.7 mm, p<0.05), and smaller gap between balloon-
stretched and implanted device diameters (-1.0±0.6 vs 3.1±2.8 mm). 
 
Conclusion: 
 
Percutaneous ASD closure using Amplatzer device is feasible
and safe in most of children. Small ASD and an appropriate size device are
predictive of success. In the larger ASD and in the younger patients, normal-
ization of ASD area to body surface area may help to choice the best treat-
ment.
 
299
 
Palliative Potts anastomosis for primary pulmonary hypertension in
children : mid-term results.
 
Jérôme Petit, Alban Baruteau, Emre Belli, Alain Serraf
 
Centre Chirurgical Marie Lannelongue, Service des Cardiopathies 
Congénitales, Le Plessis Robinson, France
 
Despite permanent progress in medical treatments, primary pulmonary
hypertension in children (PPHTC) remains a not curable disease with a severe
prognosis. Moreover, continuous intravenous treatment is particularly unac-
ceptable for the quality of survival at this age.
 
Background:
 
 Eisenmenger syndrome with large patent ductus arteriosus
carries a relatively good prognosis with long-term survival. This prompted us
to try a Potts anastomosis as surgical palliative treatment for PPHTC : direct
anastomosis between the descending aorta and the left pulmonary artery
without cardiopulmonary bypass. 
 
Aim:
 
 To assess the risks and benefits of that surgery and the mid-term
results in the first cases.
 
Material and methods:
 
 From 06/05/2004 to 23/03/2007, six children
underwent Potts anastomosis for PPHTC. Age was 2.4 to 11 years, weight 14
to 23 Kg. All were NYHA IV and experienced syncopes. All received
Bosentan, associated with continuous intravenous prostacyclin in 4 and
Sildenafil in 1. Bosentan was used in monotherapy in 1.
 
Immediate results: 
 
No death occurred during surgery.
One child died at day 12 with staphylococcus infection and major cyanosis.
This child received Bosentan monotherapy.
 
Mid term results: 
 
No death occurred during a mean follow-up of 4 years
and 2 months. For the 5 surviving patients, functional status increased from
NYHA IV to NYHA I (3 pts) and NYHA II (2 pts). No syncope occurred.
Intravenous prostacyclin therapy was stopped for 3/4 pts who received it
before. Oral treatment was continued. Potts anastomosis remained large with
right to left shunt and same pressure in pulmonary arteries and aorta. Percuta-
neous oxygen saturation in inferior limbs is stable, from 88 to 72 %, and
normal in right upper limb. All have mild to moderate polycythaemia.
 
Conclusion:
 
 Surgical Potts anastomosis is a palliative solution for PPHTC
with an acceptable perioperative risk and good mid-term results. It avoids
sudden death and allows a better quality of life in these children.
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Introduction:
 
 Kawasaki disease is the leading cause of acquired heart dis-
ease in children. Increased cardiovascular risk can be assessed by intima-
media thickness (IMT), a strong independent predictive factor for coronary
heart disease, as could be the flow-mediated vasodilatation (FMD).  However,
controversy exists about these parameters if altered in children with Kawasaki
disease.
 
Objective:
 
 The aim of our study was to study the mechanical arterial prop-
erties and to analyze endothelial function by measuring the flow-mediated
dilatation proving its alteration in Kawasaki disease patients evolving with
moderate or without coronary artery lesions. 
 
Population and methods:
 
 A study design of 29 patients who had
Kawasaki disease with no or transient or coronary artery involvement less than
4 mm of dilatation (group I), mean age 7,6 years, was compared to 30 healthy
age-matched children (group II), mean age of 8,3 years. The carotid IMT,
incremental elastic modulus, cross sectional compliance,distensibility and
FMD were determined non-invasively one year following the disease. 
 
Results:
 
 No significant difference was found with Flow-Mediated Dilata-
tion between either group, for group I (9,16 %, Standard Deviation:
SD = 5,05) and group II (8,8 %, SD = 4,56). As it was for mechanical arterial
properties, like incremental elastic modulus, vascular compliance, distensi-
bility and IMT, for group I (Mean IMT = 0,44 mm, SD = 0,028) vs (0,46 mm,
SD = 0,060) for group II.
 
Conclusions:
 
 Early evaluation of mechanical properties and endothelial
function of the arteries in patients with Kawasaki disease, who have no or little
dilatation less than 4 mm in coronary arteries, don’t show any alteration as
compared with healthy population.  
